Telegram RegisterThe public register of Telegram
Telegram profile photo for Инновации в фармацевтике

Channel

Инновации в фармацевтике

@chemrarpharma

On this record: Topic · Growth · Engagement · What this channel posts · Reactions · Posts · Citations · Telegram's recommendations · Cite this entry

13,053subscribers

-136 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of 10,000–31,623.

Register entry

Telegram ID-1001380167234
TypeChannel
Username@chemrarpharma
Description✅Новости фармацевтики, нейротехнологий и биотехнологий; ✅Кейсы цифровой трансформации фармацевтики, аналитика рынка По вопросам: @arinelAa РНК: https://knd.gov.ru/license?id=678f5cbc6b68e25950876252&registryType=bloggersPermission
Created30 August 2019 — measured — cross-checked against a third-party dataset (ext.tg_channel)
First recorded6 August 2026
Last confirmed live7 November 2026
Measurements held56
Confirmed unchanged1 time, most recently 7 November 2026
On Telegramt.me/chemrarpharma

Topic

Health & wellness — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 11 September 2026 and assigned it the closest of 31 fixed categories, at 98% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and the other topics.

Growth

13,05313,18913,1216 August 2026 — 13,189 subscribers6 August 2026 — 13,187 subscribers8 August 2026 — 13,188 subscribers9 August 2026 — 13,186 subscribers10 August 2026 — 13,182 subscribers11 August 2026 — 13,185 subscribers12 August 2026 — 13,186 subscribers13 August 2026 — 13,181 subscribers14 August 2026 — 13,182 subscribers16 August 2026 — 13,181 subscribers17 August 2026 — 13,185 subscribers18 August 2026 — 13,182 subscribers19 August 2026 — 13,181 subscribers21 August 2026 — 13,180 subscribers23 August 2026 — 13,181 subscribers24 August 2026 — 13,178 subscribers25 August 2026 — 13,180 subscribers26 August 2026 — 13,178 subscribers27 August 2026 — 13,174 subscribers28 August 2026 — 13,180 subscribers29 August 2026 — 13,175 subscribers30 August 2026 — 13,177 subscribers31 August 2026 — 13,170 subscribers1 September 2026 — 13,164 subscribers2 September 2026 — 13,163 subscribers4 September 2026 — 13,160 subscribers6 September 2026 — 13,154 subscribers9 September 2026 — 13,148 subscribers12 September 2026 — 13,142 subscribers13 September 2026 — 13,136 subscribers15 September 2026 — 13,138 subscribers17 September 2026 — 13,139 subscribers5 October 2026 — 13,133 subscribers9 October 2026 — 13,131 subscribers13 October 2026 — 13,120 subscribers14 October 2026 — 13,118 subscribers15 October 2026 — 13,116 subscribers17 October 2026 — 13,114 subscribers18 October 2026 — 13,112 subscribers18 October 2026 — 13,111 subscribers19 October 2026 — 13,113 subscribers20 October 2026 — 13,110 subscribers22 October 2026 — 13,102 subscribers23 October 2026 — 13,097 subscribers23 October 2026 — 13,089 subscribers27 October 2026 — 13,088 subscribers28 October 2026 — 13,087 subscribers29 October 2026 — 13,080 subscribers30 October 2026 — 13,077 subscribers31 October 2026 — 13,072 subscribers1 November 2026 — 13,069 subscribers3 November 2026 — 13,066 subscribers4 November 2026 — 13,065 subscribers5 November 2026 — 13,058 subscribers6 November 2026 — 13,057 subscribers7 November 2026 — 13,053 subscribers6 August 20267 November 2026
56 measurements spanning 93 days, net -136. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 13,033–13,209 and does not start at zero.
Measurement log — every subscribers count we have recorded, most recent 20 of 56
Measured (UTC)SubscribersChange
7 Nov 2026, 13:5613,053-4
6 Nov 2026, 16:3013,057-1
5 Nov 2026, 13:2813,058-7
4 Nov 2026, 12:0613,065-1
3 Nov 2026, 12:1013,066-3
1 Nov 2026, 14:4613,069-3
31 Oct 2026, 13:3713,072-5
30 Oct 2026, 14:1013,077-3
29 Oct 2026, 12:4613,080-7
28 Oct 2026, 11:3513,087-1
27 Oct 2026, 14:4813,088-1
23 Oct 2026, 23:0013,089-8
23 Oct 2026, 01:1813,097-5
22 Oct 2026, 03:3513,102-8
20 Oct 2026, 21:1213,110-3
19 Oct 2026, 22:4613,113+2
18 Oct 2026, 21:2013,111-1
18 Oct 2026, 00:0713,112-2
17 Oct 2026, 01:2913,114-2
15 Oct 2026, 23:1913,116first reading

Engagement

57 posts held, back to 20 July 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 61 pages of Telegram’s post history, 20 posts per page.

ERR · 30 days
12.2%
avg views ÷ 13,053 subscribers
Avg views / post
1,590
20 posts measured
Reaction rate
0.8%
reactions ÷ views · ER floor
Posts in window
20
of 57 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.

What these figures were computed from
WindowRolling 30 days · latest post in window 6 November 2026
Posts held57 (20 July 2026 – 6 November 2026)
Views total31,875
Reactions total255
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken8 Nov 2026, 19:08 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

What this channel posts

Photos
≈899
Videos
≈14
Links
≈4,410

Lifetime counters from Telegram’s own channel header, read 8 November 2026 — not the date at the top of this page, which is when the subscriber count was last read. A count marked ≈ was rounded by Telegram before we ever saw it — t.me prints these counters in full below 1,000 and to three significant figures above, so ≈142,000 means somewhere between 141,500 and 142,499.

Reaction mix

759 reactions across 55 posts, in 14 distinct kinds. The most used accounts for 35.4% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
👍26935.4%
🔥20527.0%
❤18924.9%
😱243.16%
😢192.50%
🥰151.98%
🙏111.45%
👏91.19%
😁70.922%
🤯30.395%
🥱30.395%
🤔20.264%
🤩20.264%
👌10.132%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 57 of the 57 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 792 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 57 most recent posts we hold, published 20 July 2026 to 6 November 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

Telegram’s own ‘edited’ marker: 7 of 20 posts held from the last 30 days (35.0%) carried it when this register last read them. The marker says a post was changed after publishing, not what it said before — this register holds the earlier wording only where an edit fell between two of its own reads (see the edit ledger and how it is measured).

6 Nov 2026, 06:27 UTC950 views17 reactionsread 8 November 2026
Photo

AbbVie и Brise Pharmaceuticals заключили сделку на $757 млн для разработки лекарств от мигрени Фармацевтический гигант объявил о заключении лицензионного соглашения с китайской Brise Pharmaceuticals. В рамках договоренности, достигнутой еще 2 года назад, стороны будут совместно работать над рядом препаратов для лечения мигрени, находящихся на ранних стадиях разработки. По условиям соглашения, AbbVie обязуется выпла…

👍12🔥3❤2

5 Nov 2026, 08:04 UTC855 views6 reactionsread 8 November 2026
Photo

Препарат для лечения атаксии Фридрейха получил статус Fast Track Designation Компания Graviton BioScience объявила, что FDA присвоило препарату GV101, находящемуся на стадии клинических испытаний, статус ускоренного рассмотрения (Fast Track Designation). GV101 – мощный селективный ингибитор протеинкиназы 2 (ROCK2), содержащий Rho/Rho-ассоциированную спиральную структуру, предназначенный для лечения атаксии Фридрейх…

👍4❤1🙏1

2 Nov 2026, 08:51 UTC≈1,200 views12 reactionsread 8 November 2026
Photo

Дайджест FDA (статусы Breakthrough therapy designation) — сентябрь 2026 года Представляем очередной выпуск нашего обновленного дайджеста FDA. В нем — уникальная подборка новостей по статусам Breakthrough therapy designation, присвоенным американским регулятором за сентябрь. Читайте нас и будьте в курсе самых последних инноваций в фармацевтике. ◾️Temab-A компании AbbVie получил два статуса «прорывной терапии» от FD…

❤5👍5🔥2

30 Oct 2026, 08:07 UTC≈1,560 views16 reactionsread 8 November 2026
Photo

FDA хочет отозвать препарат, который приносит Amgen полмиллиарда долларов в год В мае 2021 года FDA выпустило информационный документ об экспериментальном препарате для лечения редкой аутоиммунной формы васкулита. Агентство сомневалось, стоит ли одобрять первый в своем классе антагонист C5aR1 компании Amgen, и хотело, чтобы независимый консультативный комитет высказал свое мнение. В итоге препарату, продаваемому по…

😱15😢1

29 Oct 2026, 09:06 UTC≈1,460 views12 reactionsread 8 November 2026
Photo

AstraZeneca, Oracle и M42 запускают программу по гипертонии на базе ИИ В ОАЭ запускают первую программу в рамках большого международного проекта. Её суть — понять, как искусственный интеллект и медицинские данные могут сделать клинические исследования частью обычной медицинской помощи. В центре внимания — пациенты с гипертонией, у которых давление плохо поддаётся контролю. Проект реализуют AstraZeneca и Oracle Heal…

🔥6👍4❤2

28 Oct 2026, 08:25 UTC≈1,440 views12 reactionsread 8 November 2026
Photo

Препарат для лечения пигментного ретинита компании Octant получил от FDA статус орфанного Компания Octant, Inc. объявила, что американский регулятор предоставил статус орфанного препарату OCT-980 для лечения пигментного ретинита (RP). Этот статус распространяется на аутосомно-доминантный пигментный ретинит, связанный с родопсином (RHO-adRP). OCT-980 — это экспериментальный пероральный препарат на основе малой молек…

❤5🔥4👍3

27 Oct 2026, 08:28 UTC≈1,320 views12 reactionsread 8 November 2026
Photo

Biocon заключила сделку с Janssen о продаже биоаналога препарата Stelara в Китае и еще на 8 рынках Компания Biocon заключила лицензионное соглашение с Janssen Sciences Ireland на коммерциализацию Yesintek, биоаналога Stelara, на девяти новых рынках. Лицензия распространяется на Австралию, Бразилию, Китай, Гонконг, Израиль, Мексику, Новую Зеландию, Южную Корею и Казахстан. Финансовые условия сделки не разглашаются. …

👍6❤3🔥2😱1

26 Oct 2026, 08:40 UTC≈1,370 views12 reactionsread 8 November 2026
Photo

Prilenia и Ferrer получили разрешение ЕС на проведение III фазы КИ препарата от болезни Хантингтона В глобальном рандомизированном двойном слепом плацебо-контролируемом исследовании придопидина примут участие около 400 человек с ранней и средней стадией болезни Хантингтона, определяемой по показателю общей функциональной способности (TFC) от 7 до 13. В ходе исследования будет оценено влияние перорального приема пре…

👍4🔥4❤2🤯2

23 Oct 2026, 09:01 UTC≈1,500 views10 reactionsread 8 November 2026
Photo

Препарат против аспергиллеза от Shionogi и F2G демонстрирует долгосрочную пользу Больные, получавшие лечение пероральным препаратом olorofim, были выписаны из больницы раньше, чем пациенты из компараторной группы. В исследовании приняли участие 225 взрослых с инвазивным аспергиллезом, у которых инфекция либо рефрактерна, либо непригодна для азоловой терапии. Ранее FDA отказало препарату в одобрении из-за недостаточ…

👍5❤3🔥2

22 Oct 2026, 12:59 UTC≈1,550 views8 reactionsread 8 November 2026
Photo

Приглашаем вас на демо-день Кейс-чемпионата «Театр — Наука — Искусство», который состоится 27 октября 2026 года в Концертном зале МФТИ (г. Долгопрудный Институтский пер., д. 9). Расписание вечера: 18:00 сбор гостей, фуршет 19:00 приветственное слово организаторов 19:40 антракт, фуршет 20:00 выступления финалистов 21:30 торжественное объявление победителей Демо-день — финальное событие проекта «Резиденция и Кейс-че…

❤3👍3🔥2

22 Oct 2026, 08:09 UTC≈1,920 views20 reactionsread 8 November 2026
Photo

FDA одобрило препарат от гепатита B для контроля вируса без пожизненной терапии Hibsago (bepirovirsen) британской фармацевтической компании GSK позволяет пациентам с инфекцией печени контролировать вирус после прекращения лечения. Это первый антисмысловой олигонуклеотид, одобренный американским регулятором для лечения хронического гепатита B. Под руководством нового генерального директора Люка Милса фармгигант стре…

❤13👍6👏1

21 Oct 2026, 08:16 UTC≈1,460 views12 reactionsread 8 November 2026
Photo

FDA присвоило статус Fast Track Designation химиоиммунотерапевтическому ADC-препарату для лечения рака поджелудочной железы компании Medicovestor Компания готовится начать международное многоцентровое клиническое исследование I фазы, оценивающее безопасность, переносимость, фармакокинетику и предварительную противоопухолевую активность MC001 у пациентов с распространенным или метастатическим раком поджелудочной желе…

👍4🔥4🤩2🙏2

Showing the 12 most recent of 57 posts we hold for @chemrarpharma. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Republishes

Channels on the register whose posts this channel has forwarded.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 4 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Names

Channels on the register whose handles appear in this channel's posts.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Appears in Telegram’s recommendations for other channels

The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.

Без рецепта
@bezrec · 32,023
Telegram ranks this channel #9 of 98 here — alongside 97 others — read 5 September 2026
Подслушано | Аптека
@podslushano_apteka · 23,858
Telegram ranks this channel #44 of 83 here — alongside 82 others — read 16 September 2026
Слёзы Фармацевта
@katya_farm · 40,402
Telegram ranks this channel #46 of 79 here — alongside 78 others — read 5 September 2026
Медач | Medical Channel
@medach · 27,944
Telegram ranks this channel #50 of 97 here — alongside 96 others — read 10 September 2026

This channel appears in 4 seed channels' Telegram-generated recommendation lists in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 7 November 2026 — this entry's latest reading, not the date you are reading this.

“Инновации в фармацевтике” (@chemrarpharma), 13,053 subscribers as measured 7 November 2026. Telegram Register, tgregister.com/channel/chemrarpharma.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.